statistiche ricercatore

Continente	#
EU - Europa	1.596
NA - Nord America	243
AS - Asia	235
Continente sconosciuto - Info sul continente non disponibili	35
SA - Sud America	31
AF - Africa	6
Totale	2.146

Nazione	#
IT - Italia	1.560
US - Stati Uniti d'America	220
SG - Singapore	79
CN - Cina	57
VN - Vietnam	46
BD - Bangladesh	24
BR - Brasile	14
FR - Francia	14
CA - Canada	10
HK - Hong Kong	8
FI - Finlandia	6
AR - Argentina	5
MX - Messico	5
DE - Germania	4
JP - Giappone	4
EC - Ecuador	3
JM - Giamaica	3
JO - Giordania	3
PY - Paraguay	3
EG - Egitto	2
ES - Italia	2
PH - Filippine	2
PK - Pakistan	2
TH - Thailandia	2
VE - Venezuela	2
ZA - Sudafrica	2
AL - Albania	1
AT - Austria	1
BH - Bahrain	1
BO - Bolivia	1
BZ - Belize	1
CH - Svizzera	1
CO - Colombia	1
CR - Costa Rica	1
CU - Cuba	1
DZ - Algeria	1
GB - Regno Unito	1
HN - Honduras	1
HU - Ungheria	1
ID - Indonesia	1
IE - Irlanda	1
IN - India	1
MA - Marocco	1
MN - Mongolia	1
MY - Malesia	1
NL - Olanda	1
PE - Perù	1
PS - Palestinian Territory	1
RU - Federazione Russa	1
SE - Svezia	1
TR - Turchia	1
TW - Taiwan	1
UA - Ucraina	1
UY - Uruguay	1
VG - Isole Vergini Britanniche	1
Totale	2.111

Nome	#
IL-27 induces the expression of IDO and PD-L1 in human cancer cells	220
Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma	201
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity	201
A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma	199
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells	197
A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.	185
Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence	178
How many mutations does it take to make a uveal melanoma?	175
Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab	137
Cytokine-induced guanylate binding protein 1 (GBP1) release from human ovarian cancer cells	134
HGF-producing mesenchymal stromal cells support chronic lymphocytic leukemic B cells survival	122
Il‐27 mediates pd‐l1 expression and release by human mesothelioma cells	105
IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells	92
Totale	2.146

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	126	0	0	12	9	9	15	4	31	11	16	5	14
2022/2023	186	14	15	5	15	24	29	0	15	29	1	35	4
2023/2024	134	4	20	1	18	19	29	8	11	4	6	5	9
2024/2025	370	7	27	7	41	42	35	24	63	12	22	42	48
2025/2026	673	93	11	49	50	95	47	96	40	54	67	54	17
2026/2027	93	58	17	18	0	0	0	0	0	0	0	0	0
Totale													2.146